| # | Drug | Count |
|---|---|---|
| 0 | RISPERIDONE | 40 |
| 1 | CLONAZEPAM | 28 |
| 2 | OLANZAPINE | 28 |
| 3 | HALOPERIDOL | 27 |
| 4 | HALOPERIDOL LACTATE | 27 |
| 5 | LITHIUM | 25 |
| 6 | LITHIUM BROMATUM | 25 |
| 7 | ARIPIPRAZOLE | 24 |
| 8 | ARIPIPRAZOLE ORAL | 24 |
| 9 | ARIPIPRAZOLE ORALLY DISINTEGRATING | 24 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | QUAZEPAM | 1 | 0.0033 |
| 1 | HALOPERIDOL LACTATE | 27 | 0.0011 |
| 2 | LITHIUM | 25 | 0.0010 |
| 3 | VALPROIC ACID | 21 | 0.0007 |
| 4 | RISPERIDONE | 40 | 0.0005 |
| 5 | GAUNFACINE | 2 | 0.0005 |
| 6 | OLANZAPINE | 28 | 0.0004 |
| 7 | LAMOTIRIGINE | 22 | 0.0003 |
| 8 | LAMOTRIGINE CHEWABLE DISPERSIBLE | 22 | 0.0003 |
| 9 | GUANFACINE | 2 | 0.0002 |
| # | Drug class | Count |
|---|---|---|
| 0 | Atypical Antipsychotic [EPC] | 48 |
| 1 | Benzodiazepine [EPC] | 31 |
| 2 | Typical Antipsychotic [EPC] | 27 |
| 3 | Mood Stabilizer [EPC] | 25 |
| 4 | Anti-epileptic Agent [EPC] | 22 |
| 5 | Central alpha-2 Adrenergic Agonist [EPC] | 2 |
| 6 | Insulin Analog [EPC] | 2 |
| 7 | Angiotensin 2 Receptor Blocker [EPC] | 1 |
| 8 | Aromatase Inhibitor [EPC] | 1 |
| 9 | BCL-2 Inhibitor [EPC] | 1 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Typical Antipsychotic [EPC] | 27 | 0.0011 |
| 1 | Vesicular Monoamine Transporter 2 Inhibitor [EPC] | 1 | 0.0008 |
| 2 | Dopamine-2 Receptor Antagonist [EPC] | 1 | 0.0001 |
| 3 | Echinocandin Antifungal [EPC] | 1 | 0.0001 |
| 4 | Mood Stabilizer [EPC] | 25 | 0.0001 |
| 5 | Atypical Antipsychotic [EPC] | 48 | 0.0001 |
| 6 | Anti-epileptic Agent [EPC] | 22 | 0.0001 |
| 7 | Sulfone [EPC] | 1 | 0.0001 |
| 8 | Benzodiazepine [EPC] | 31 | 0.0000 |
| 9 | Gonadotropin Releasing Hormone Receptor Antagonist [EPC] | 1 | 0.0000 |